-
1
-
-
27744561283
-
Renal cell carcinoma: current status and future prospects
-
Drucker B.J. Renal cell carcinoma: current status and future prospects. Cancer Treat. Rev. 31 (2005) 536-545
-
(2005)
Cancer Treat. Rev.
, vol.31
, pp. 536-545
-
-
Drucker, B.J.1
-
3
-
-
0036606414
-
Induction and regulation of tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand-mediated apoptosis in renal cell carcinoma
-
Griffith T.S., Fialkov J.M., Scott D.L., Azuhata T., Williams R.D., Wall N.R., Altieri D.C., and Sandler A.D. Induction and regulation of tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand-mediated apoptosis in renal cell carcinoma. Cancer Res. 62 (2002) 3093-3099
-
(2002)
Cancer Res.
, vol.62
, pp. 3093-3099
-
-
Griffith, T.S.1
Fialkov, J.M.2
Scott, D.L.3
Azuhata, T.4
Williams, R.D.5
Wall, N.R.6
Altieri, D.C.7
Sandler, A.D.8
-
4
-
-
30344455043
-
Targeting death receptors in bladder, prostate and renal cancer
-
O'Kane H.F., Watson C.J., Johnston S.R., Petak I., Watson R.W., and Williamson K.E. Targeting death receptors in bladder, prostate and renal cancer. J. Urol. 175 (2006) 432-438
-
(2006)
J. Urol.
, vol.175
, pp. 432-438
-
-
O'Kane, H.F.1
Watson, C.J.2
Johnston, S.R.3
Petak, I.4
Watson, R.W.5
Williamson, K.E.6
-
5
-
-
0033790715
-
TRAIL receptor-2 signals apoptosis through FADD and caspase-8
-
Bodmer J.L., Holler N., Reynard S., Vinciguerra P., Schneider P., Juo P., Blenis J., and Tschopp J. TRAIL receptor-2 signals apoptosis through FADD and caspase-8. Nat. Cell Biol. 2 (2000) 241-243
-
(2000)
Nat. Cell Biol.
, vol.2
, pp. 241-243
-
-
Bodmer, J.L.1
Holler, N.2
Reynard, S.3
Vinciguerra, P.4
Schneider, P.5
Juo, P.6
Blenis, J.7
Tschopp, J.8
-
6
-
-
0031405585
-
TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB
-
Schneider P., Thome M., Burns K., Bodmer J.L., Hofmann K., Kataoka T., Holler N., and Tschopp J. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB. Immunity 7 (1997) 831-836
-
(1997)
Immunity
, vol.7
, pp. 831-836
-
-
Schneider, P.1
Thome, M.2
Burns, K.3
Bodmer, J.L.4
Hofmann, K.5
Kataoka, T.6
Holler, N.7
Tschopp, J.8
-
7
-
-
0033662433
-
Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5
-
Kischkel F.C., Lawrence D.A., Chuntharapai A., Schow P., Kim K.J., and Ashkenazi A. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity 12 (2000) 611-620
-
(2000)
Immunity
, vol.12
, pp. 611-620
-
-
Kischkel, F.C.1
Lawrence, D.A.2
Chuntharapai, A.3
Schow, P.4
Kim, K.J.5
Ashkenazi, A.6
-
8
-
-
0033667778
-
FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2
-
Sprick M.R., Weigand M.A., Rieser E., Rauch C.T., Juo P., Blenis J., Krammer P.H., and Walczak H. FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. Immunity 12 (2000) 599-609
-
(2000)
Immunity
, vol.12
, pp. 599-609
-
-
Sprick, M.R.1
Weigand, M.A.2
Rieser, E.3
Rauch, C.T.4
Juo, P.5
Blenis, J.6
Krammer, P.H.7
Walczak, H.8
-
9
-
-
0030792712
-
Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors
-
Sheridan J.P., Marsters S.A., Pitti R.M., Gurney A., Skubatch M., Baldwin D., Ramakrishnan L., Gray C.L., Baker K., Wood W.I., Goddard A.D., Godowski P., and Ashkenazi A. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 277 (1997) 818-821
-
(1997)
Science
, vol.277
, pp. 818-821
-
-
Sheridan, J.P.1
Marsters, S.A.2
Pitti, R.M.3
Gurney, A.4
Skubatch, M.5
Baldwin, D.6
Ramakrishnan, L.7
Gray, C.L.8
Baker, K.9
Wood, W.I.10
Goddard, A.D.11
Godowski, P.12
Ashkenazi, A.13
-
10
-
-
25144433291
-
Radiotherapy sensitization by tumor-specific TRAIL gene targeting improves survival of mice bearing human non-small cell lung cancer
-
Zhang X., Cheung R.M., Komaki R., Fang B., and Chang J.Y. Radiotherapy sensitization by tumor-specific TRAIL gene targeting improves survival of mice bearing human non-small cell lung cancer. Clin. Cancer Res. 11 (2005) 6657-6668
-
(2005)
Clin. Cancer Res.
, vol.11
, pp. 6657-6668
-
-
Zhang, X.1
Cheung, R.M.2
Komaki, R.3
Fang, B.4
Chang, J.Y.5
-
11
-
-
0030762815
-
An antagonist decoy receptor and a death domain-containing receptor for TRAIL
-
Pan G., Ni J., Wei Y.F., Yu G., Gentz R., and Dixit V.M. An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 277 (1997) 815-818
-
(1997)
Science
, vol.277
, pp. 815-818
-
-
Pan, G.1
Ni, J.2
Wei, Y.F.3
Yu, G.4
Gentz, R.5
Dixit, V.M.6
-
12
-
-
0035912060
-
Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways
-
Suliman A., Lam A., Datta R., and Srivastava R.K. Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways. Oncogene 20 (2001) 2122-2133
-
(2001)
Oncogene
, vol.20
, pp. 2122-2133
-
-
Suliman, A.1
Lam, A.2
Datta, R.3
Srivastava, R.K.4
-
13
-
-
27644543263
-
Sulindac sulfide-induced apoptosis is enhanced by a small-molecule Bcl-2 inhibitor and by TRAIL in human colon cancer cells overexpressing Bcl-2
-
Sinicrope F.A., and Penington R.C. Sulindac sulfide-induced apoptosis is enhanced by a small-molecule Bcl-2 inhibitor and by TRAIL in human colon cancer cells overexpressing Bcl-2. Mol. Cancer Ther. 4 (2005) 1475-1483
-
(2005)
Mol. Cancer Ther.
, vol.4
, pp. 1475-1483
-
-
Sinicrope, F.A.1
Penington, R.C.2
-
14
-
-
32544438637
-
c-FLIP inhibits chemotherapy-induced colorectal cancer cell death
-
Longley D.B., Wilson T.R., McEwan M., Allen W.L., McDermott U., Galligan L., and Johnston P.G. c-FLIP inhibits chemotherapy-induced colorectal cancer cell death. Oncogene 25 (2006) 838-848
-
(2006)
Oncogene
, vol.25
, pp. 838-848
-
-
Longley, D.B.1
Wilson, T.R.2
McEwan, M.3
Allen, W.L.4
McDermott, U.5
Galligan, L.6
Johnston, P.G.7
-
15
-
-
33344471933
-
Persistent inhibition of FLIP(L) expression by lentiviral small hairpin RNA delivery restores death-receptor-induced apoptosis in neuroblastoma cells
-
Flahaut M., Muhlethaler-Mottet A., Auderset K., Bourloud K.B., Meier R., Popovic M.B., Joseph J.M., and Gross N. Persistent inhibition of FLIP(L) expression by lentiviral small hairpin RNA delivery restores death-receptor-induced apoptosis in neuroblastoma cells. Apoptosis 11 (2006) 255-263
-
(2006)
Apoptosis
, vol.11
, pp. 255-263
-
-
Flahaut, M.1
Muhlethaler-Mottet, A.2
Auderset, K.3
Bourloud, K.B.4
Meier, R.5
Popovic, M.B.6
Joseph, J.M.7
Gross, N.8
-
16
-
-
30344452318
-
Chemotherapy and TRAIL-mediated colon cancer cell death: the roles of p53, TRAIL receptors, and c-FLIP
-
Galligan L., Longley D.B., McEwan M., Wilson T.R., McLaughlin K., and Johnston P.G. Chemotherapy and TRAIL-mediated colon cancer cell death: the roles of p53, TRAIL receptors, and c-FLIP. Mol. Cancer Ther. 4 (2005) 2026-2036
-
(2005)
Mol. Cancer Ther.
, vol.4
, pp. 2026-2036
-
-
Galligan, L.1
Longley, D.B.2
McEwan, M.3
Wilson, T.R.4
McLaughlin, K.5
Johnston, P.G.6
-
17
-
-
11244328926
-
Fas-associated protein with death domain (FADD)-independent recruitment of c-FLIPL to death receptor 5
-
Jin T.G., Kurakin A., Benhaga N., Abe K., Mohseni M., Sandra F., Song K., Kay B.K., and Khosravi-Far R. Fas-associated protein with death domain (FADD)-independent recruitment of c-FLIPL to death receptor 5. J. Biol. Chem. 279 (2004) 55594-55601
-
(2004)
J. Biol. Chem.
, vol.279
, pp. 55594-55601
-
-
Jin, T.G.1
Kurakin, A.2
Benhaga, N.3
Abe, K.4
Mohseni, M.5
Sandra, F.6
Song, K.7
Kay, B.K.8
Khosravi-Far, R.9
-
18
-
-
0242656497
-
Death receptor-induced cell killing
-
Thorburn A. Death receptor-induced cell killing. Cell Signal. 16 (2004) 139-144
-
(2004)
Cell Signal.
, vol.16
, pp. 139-144
-
-
Thorburn, A.1
-
19
-
-
0034508661
-
The complexity of TNF-related apoptosis-inducing ligand
-
Abe K., Kurakin A., Mohseni-Maybodi M., Kay B., and Khosravi-Far R. The complexity of TNF-related apoptosis-inducing ligand. Ann. N. Y. Acad. Sci. 926 (2000) 52-63
-
(2000)
Ann. N. Y. Acad. Sci.
, vol.926
, pp. 52-63
-
-
Abe, K.1
Kurakin, A.2
Mohseni-Maybodi, M.3
Kay, B.4
Khosravi-Far, R.5
-
20
-
-
32944475745
-
Sulforaphane sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-resistant hepatoma cells to TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of DR5
-
Kim H., Kim E.H., Eom Y.W., Kim W.H., Kwon T.K., Lee S.J., and Choi K.S. Sulforaphane sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-resistant hepatoma cells to TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of DR5. Cancer Res. 66 (2006) 1740-1750
-
(2006)
Cancer Res.
, vol.66
, pp. 1740-1750
-
-
Kim, H.1
Kim, E.H.2
Eom, Y.W.3
Kim, W.H.4
Kwon, T.K.5
Lee, S.J.6
Choi, K.S.7
-
21
-
-
17644378775
-
c-FLIPR, a new regulator of death receptor-induced apoptosis
-
Golks A., Brenner D., Fritsch C., Krammer P.H., and Lavrik I.N. c-FLIPR, a new regulator of death receptor-induced apoptosis. J. Biol. Chem. 280 (2005) 14507-14513
-
(2005)
J. Biol. Chem.
, vol.280
, pp. 14507-14513
-
-
Golks, A.1
Brenner, D.2
Fritsch, C.3
Krammer, P.H.4
Lavrik, I.N.5
-
22
-
-
4944248109
-
Persistent c-FLIP(L) expression is necessary and sufficient to maintain resistance to tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in prostate cancer
-
Zhang X., Jin T.G., Yang H., DeWolf W.C., Khosravi-Far R., and Olumi A.F. Persistent c-FLIP(L) expression is necessary and sufficient to maintain resistance to tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in prostate cancer. Cancer Res. 64 (2004) 7086-7091
-
(2004)
Cancer Res.
, vol.64
, pp. 7086-7091
-
-
Zhang, X.1
Jin, T.G.2
Yang, H.3
DeWolf, W.C.4
Khosravi-Far, R.5
Olumi, A.F.6
-
23
-
-
21144438719
-
Synthetic triterpenoids cooperate with tumor necrosis factor-related apoptosis-inducing ligand to induce apoptosis of breast cancer cells
-
Hyer M.L., Croxton R., Krajewska M., Krajewski S., Kress C.L., Lu M., Suh N., Sporn M.B., Cryns V.L., Zapata J.M., and Reed J.C. Synthetic triterpenoids cooperate with tumor necrosis factor-related apoptosis-inducing ligand to induce apoptosis of breast cancer cells. Cancer Res. 65 (2005) 4799-4808
-
(2005)
Cancer Res.
, vol.65
, pp. 4799-4808
-
-
Hyer, M.L.1
Croxton, R.2
Krajewska, M.3
Krajewski, S.4
Kress, C.L.5
Lu, M.6
Suh, N.7
Sporn, M.B.8
Cryns, V.L.9
Zapata, J.M.10
Reed, J.C.11
-
24
-
-
2942526515
-
The sequential treatment with ionizing radiation followed by TRAIL/Apo-2L reduces tumor growth and induces apoptosis of breast tumor xenografts in nude mice
-
Shankar S., Singh T.R., Chen X., Thakkar H., Firnin J., and Srivastava R.K. The sequential treatment with ionizing radiation followed by TRAIL/Apo-2L reduces tumor growth and induces apoptosis of breast tumor xenografts in nude mice. Int. J. Oncol. 24 (2004) 1133-1140
-
(2004)
Int. J. Oncol.
, vol.24
, pp. 1133-1140
-
-
Shankar, S.1
Singh, T.R.2
Chen, X.3
Thakkar, H.4
Firnin, J.5
Srivastava, R.K.6
-
25
-
-
0041633807
-
Apoptosis induction in prostate cancer cells and xenografts by combined treatment with Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand and CPT-11
-
Ray S., and Almasan A. Apoptosis induction in prostate cancer cells and xenografts by combined treatment with Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand and CPT-11. Cancer Res. 63 (2003) 4713-4723
-
(2003)
Cancer Res.
, vol.63
, pp. 4713-4723
-
-
Ray, S.1
Almasan, A.2
-
26
-
-
13144297792
-
Doxorubicin increases the effectiveness of Apo2L/TRAIL for tumor growth inhibition of prostate cancer xenografts
-
El-Zawahry A., McKillop J., and Voelkel-Johnson C. Doxorubicin increases the effectiveness of Apo2L/TRAIL for tumor growth inhibition of prostate cancer xenografts. BMC Cancer 5 (2005) 2
-
(2005)
BMC Cancer
, vol.5
, pp. 2
-
-
El-Zawahry, A.1
McKillop, J.2
Voelkel-Johnson, C.3
-
27
-
-
6944247634
-
Tissue distribution, stability, and pharmacokinetics of Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand in human colon carcinoma COLO205 tumor-bearing nude mice
-
Xiang H., Nguyen C.B., Kelley S.K., Dybdal N., and Escandon E. Tissue distribution, stability, and pharmacokinetics of Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand in human colon carcinoma COLO205 tumor-bearing nude mice. Drug. Metab. Dispos. 32 (2004) 1230-1238
-
(2004)
Drug. Metab. Dispos.
, vol.32
, pp. 1230-1238
-
-
Xiang, H.1
Nguyen, C.B.2
Kelley, S.K.3
Dybdal, N.4
Escandon, E.5
-
28
-
-
16444381759
-
Overexpression of soluble TRAIL induces apoptosis in human lung adenocarcinoma and inhibits growth of tumor xenografts in nude mice
-
Shi J., Zheng D., Liu Y., Sham M.H., Tam P., Farzaneh F., and Xu R. Overexpression of soluble TRAIL induces apoptosis in human lung adenocarcinoma and inhibits growth of tumor xenografts in nude mice. Cancer Res. 65 (2005) 1687-1692
-
(2005)
Cancer Res.
, vol.65
, pp. 1687-1692
-
-
Shi, J.1
Zheng, D.2
Liu, Y.3
Sham, M.H.4
Tam, P.5
Farzaneh, F.6
Xu, R.7
-
29
-
-
33747195574
-
Mcl-1L cleavage is involved in TRAIL-R1 and TRAIL-R2 mediated apoptosis induced by HGS-ETR1 and HGS-ETR2 human mAb in myeloma cells
-
Menoret E., Gomez-Bougie P., Geffroy-Luseau A., Daniels S., Moreau P., Le Gouill S., Harousseau J.L., Bataille R., Amiot M., and Pellat-Deceunynck C. Mcl-1L cleavage is involved in TRAIL-R1 and TRAIL-R2 mediated apoptosis induced by HGS-ETR1 and HGS-ETR2 human mAb in myeloma cells. Blood (2006)
-
(2006)
Blood
-
-
Menoret, E.1
Gomez-Bougie, P.2
Geffroy-Luseau, A.3
Daniels, S.4
Moreau, P.5
Le Gouill, S.6
Harousseau, J.L.7
Bataille, R.8
Amiot, M.9
Pellat-Deceunynck, C.10
-
30
-
-
33747829837
-
Combined treatment of colorectal tumours with agonistic TRAIL receptor antibodies HGS-ETR1 and HGS-ETR2 and radiotherapy: enhanced effects in vitro and dose-dependent growth delay in vivo
-
Marini P., Denzinger S., Schiller D., Kauder S., Welz S., Humphreys R., Daniel P.T., Jendrossek V., Budach W., and Belka C. Combined treatment of colorectal tumours with agonistic TRAIL receptor antibodies HGS-ETR1 and HGS-ETR2 and radiotherapy: enhanced effects in vitro and dose-dependent growth delay in vivo. Oncogene 25 (2006) 5145-5154
-
(2006)
Oncogene
, vol.25
, pp. 5145-5154
-
-
Marini, P.1
Denzinger, S.2
Schiller, D.3
Kauder, S.4
Welz, S.5
Humphreys, R.6
Daniel, P.T.7
Jendrossek, V.8
Budach, W.9
Belka, C.10
-
31
-
-
0025033870
-
Orthotopic implantation is essential for the selection, growth and metastasis of human renal cell cancer in nude mice [corrected]
-
Fidler I.J., Naito S., and Pathak S. Orthotopic implantation is essential for the selection, growth and metastasis of human renal cell cancer in nude mice [corrected]. Cancer Metastasis Rev. 9 (1990) 149-165
-
(1990)
Cancer Metastasis Rev.
, vol.9
, pp. 149-165
-
-
Fidler, I.J.1
Naito, S.2
Pathak, S.3
-
32
-
-
0024588778
-
In vivo selection of human renal cell carcinoma cells with high metastatic potential in nude mice
-
Naito S., Walker S.M., and Fidler I.J. In vivo selection of human renal cell carcinoma cells with high metastatic potential in nude mice. Clin. Exp. Metastasis 7 (1989) 381-389
-
(1989)
Clin. Exp. Metastasis
, vol.7
, pp. 381-389
-
-
Naito, S.1
Walker, S.M.2
Fidler, I.J.3
-
33
-
-
0027934194
-
Organ site-dependent expression of basic fibroblast growth factor in human renal cell carcinoma cells
-
Singh R.K., Bucana C.D., Gutman M., Fan D., Wilson M.R., and Fidler I.J. Organ site-dependent expression of basic fibroblast growth factor in human renal cell carcinoma cells. Am. J. Pathol. 145 (1994) 365-374
-
(1994)
Am. J. Pathol.
, vol.145
, pp. 365-374
-
-
Singh, R.K.1
Bucana, C.D.2
Gutman, M.3
Fan, D.4
Wilson, M.R.5
Fidler, I.J.6
-
34
-
-
24944458177
-
Activity of selective fully human agonistic antibodies to the TRAIL death receptors TRAIL-R1 and TRAIL-R2 in primary and cultured lymphoma cells: induction of apoptosis and enhancement of doxorubicin- and bortezomib-induced cell death
-
Georgakis G.V., Li Y., Humphreys R., Andreeff M., O'Brien S., Younes M., Carbone A., Albert V., and Younes A. Activity of selective fully human agonistic antibodies to the TRAIL death receptors TRAIL-R1 and TRAIL-R2 in primary and cultured lymphoma cells: induction of apoptosis and enhancement of doxorubicin- and bortezomib-induced cell death. Br. J. Haematol. 130 (2005) 501-510
-
(2005)
Br. J. Haematol.
, vol.130
, pp. 501-510
-
-
Georgakis, G.V.1
Li, Y.2
Humphreys, R.3
Andreeff, M.4
O'Brien, S.5
Younes, M.6
Carbone, A.7
Albert, V.8
Younes, A.9
-
35
-
-
32444446274
-
Functional expression of TRAIL receptors TRAIL-R1 and TRAIL-R2 in esophageal adenocarcinoma
-
Younes M., Georgakis G.V., Rahmani M., Beer D., and Younes A. Functional expression of TRAIL receptors TRAIL-R1 and TRAIL-R2 in esophageal adenocarcinoma. Eur. J. Cancer 42 (2006) 542-547
-
(2006)
Eur. J. Cancer
, vol.42
, pp. 542-547
-
-
Younes, M.1
Georgakis, G.V.2
Rahmani, M.3
Beer, D.4
Younes, A.5
-
36
-
-
33646403907
-
Monoclonal antibody to tumor necrosis factor-related apoptosis-inducing ligand receptor 2 (TRAIL-R2) induces apoptosis in primary renal cell carcinoma cells in vitro and inhibits tumor growth in vivo
-
Zeng Y., Wu X.X., Fiscella M., Shimada O., Humphreys R., Albert V., and Kakehi Y. Monoclonal antibody to tumor necrosis factor-related apoptosis-inducing ligand receptor 2 (TRAIL-R2) induces apoptosis in primary renal cell carcinoma cells in vitro and inhibits tumor growth in vivo. Int. J. Oncol. 28 (2006) 421-430
-
(2006)
Int. J. Oncol.
, vol.28
, pp. 421-430
-
-
Zeng, Y.1
Wu, X.X.2
Fiscella, M.3
Shimada, O.4
Humphreys, R.5
Albert, V.6
Kakehi, Y.7
-
37
-
-
17444404554
-
Reduction of the antiapoptotic protein cFLIP enhances the susceptibility of human renal cancer cells to TRAIL apoptosis
-
Brooks A.D., and Sayers T.J. Reduction of the antiapoptotic protein cFLIP enhances the susceptibility of human renal cancer cells to TRAIL apoptosis. Cancer Immunol. Immunother. 54 (2005) 499-505
-
(2005)
Cancer Immunol. Immunother.
, vol.54
, pp. 499-505
-
-
Brooks, A.D.1
Sayers, T.J.2
-
38
-
-
0035476255
-
Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of human melanoma is regulated by smac/DIABLO release from mitochondria
-
Zhang X.D., Zhang X.Y., Gray C.P., Nguyen T., and Hersey P. Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of human melanoma is regulated by smac/DIABLO release from mitochondria. Cancer Res. 61 (2001) 7339-7348
-
(2001)
Cancer Res.
, vol.61
, pp. 7339-7348
-
-
Zhang, X.D.1
Zhang, X.Y.2
Gray, C.P.3
Nguyen, T.4
Hersey, P.5
-
39
-
-
0037100434
-
IFN-beta pretreatment sensitizes human melanoma cells to TRAIL/Apo2 ligand-induced apoptosis
-
Chawla-Sarkar M., Leaman D.W., Jacobs B.S., and Borden E.C. IFN-beta pretreatment sensitizes human melanoma cells to TRAIL/Apo2 ligand-induced apoptosis. J. Immunol. 169 (2002) 847-855
-
(2002)
J. Immunol.
, vol.169
, pp. 847-855
-
-
Chawla-Sarkar, M.1
Leaman, D.W.2
Jacobs, B.S.3
Borden, E.C.4
-
40
-
-
0035851189
-
Identification of inhibitors of TRAIL-induced death (ITIDs) in the TRAIL-sensitive colon carcinoma cell line SW480 using a genetic approach
-
Burns T.F., and El-Deiry W.S. Identification of inhibitors of TRAIL-induced death (ITIDs) in the TRAIL-sensitive colon carcinoma cell line SW480 using a genetic approach. J. Biol. Chem. 276 (2001) 37879-37886
-
(2001)
J. Biol. Chem.
, vol.276
, pp. 37879-37886
-
-
Burns, T.F.1
El-Deiry, W.S.2
-
41
-
-
0036131142
-
Tumor-cell resistance to death receptor-induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax
-
LeBlanc H., Lawrence D., Varfolomeev E., Totpal K., Morlan J., Schow P., Fong S., Schwall R., Sinicropi D., and Ashkenazi A. Tumor-cell resistance to death receptor-induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax. Nat. Med. 8 (2002) 274-281
-
(2002)
Nat. Med.
, vol.8
, pp. 274-281
-
-
LeBlanc, H.1
Lawrence, D.2
Varfolomeev, E.3
Totpal, K.4
Morlan, J.5
Schow, P.6
Fong, S.7
Schwall, R.8
Sinicropi, D.9
Ashkenazi, A.10
-
42
-
-
12544255082
-
Receptor-selective mutants of apoptosis-inducing ligand 2/tumor necrosis factor-related apoptosis-inducing ligand reveal a greater contribution of death receptor (DR) 5 than DR4 to apoptosis signaling
-
Kelley R.F., Totpal K., Lindstrom S.H., Mathieu M., Billeci K., Deforge L., Pai R., Hymowitz S.G., and Ashkenazi A. Receptor-selective mutants of apoptosis-inducing ligand 2/tumor necrosis factor-related apoptosis-inducing ligand reveal a greater contribution of death receptor (DR) 5 than DR4 to apoptosis signaling. J. Biol. Chem. 280 (2005) 2205-2212
-
(2005)
J. Biol. Chem.
, vol.280
, pp. 2205-2212
-
-
Kelley, R.F.1
Totpal, K.2
Lindstrom, S.H.3
Mathieu, M.4
Billeci, K.5
Deforge, L.6
Pai, R.7
Hymowitz, S.G.8
Ashkenazi, A.9
-
43
-
-
0034725664
-
Temperature-sensitive differential affinity of TRAIL for its receptors DR5 is the highest affinity receptor
-
Truneh A., Sharma S., Silverman C., Khandekar S., Reddy M.P., Deen K.C., McLaughlin M.M., Srinivasula S.M., Livi G.P., Marshall L.A., Alnemri E.S., Williams W.V., and Doyle M.L. Temperature-sensitive differential affinity of TRAIL for its receptors DR5 is the highest affinity receptor. J. Biol. Chem. 275 (2000) 23319-23325
-
(2000)
J. Biol. Chem.
, vol.275
, pp. 23319-23325
-
-
Truneh, A.1
Sharma, S.2
Silverman, C.3
Khandekar, S.4
Reddy, M.P.5
Deen, K.C.6
McLaughlin, M.M.7
Srinivasula, S.M.8
Livi, G.P.9
Marshall, L.A.10
Alnemri, E.S.11
Williams, W.V.12
Doyle, M.L.13
-
44
-
-
27944483706
-
Cisplatin-dependent upregulation of death receptors 4 and 5 augments induction of apoptosis by TNF-related apoptosis-inducing ligand against esophageal squamous cell carcinoma
-
Kondo K., Yamasaki S., Sugie T., Teratani N., Kan T., Imamura M., and Shimada Y. Cisplatin-dependent upregulation of death receptors 4 and 5 augments induction of apoptosis by TNF-related apoptosis-inducing ligand against esophageal squamous cell carcinoma. Int. J. Cancer 118 (2006) 230-242
-
(2006)
Int. J. Cancer
, vol.118
, pp. 230-242
-
-
Kondo, K.1
Yamasaki, S.2
Sugie, T.3
Teratani, N.4
Kan, T.5
Imamura, M.6
Shimada, Y.7
-
45
-
-
0032522463
-
p53-dependent and -independent regulation of the death receptor KILLER/DR5 gene expression in response to genotoxic stress and tumor necrosis factor alpha
-
Sheikh M.S., Burns T.F., Huang Y., Wu G.S., Amundson S., Brooks K.S., Fornace Jr. A.J., and el-Deiry W.S. p53-dependent and -independent regulation of the death receptor KILLER/DR5 gene expression in response to genotoxic stress and tumor necrosis factor alpha. Cancer Res. 58 (1998) 1593-1598
-
(1998)
Cancer Res.
, vol.58
, pp. 1593-1598
-
-
Sheikh, M.S.1
Burns, T.F.2
Huang, Y.3
Wu, G.S.4
Amundson, S.5
Brooks, K.S.6
Fornace Jr., A.J.7
el-Deiry, W.S.8
-
46
-
-
0033989422
-
Increased expression of death receptors 4 and 5 synergizes the apoptosis response to combined treatment with etoposide and TRAIL
-
Gibson S.B., Oyer R., Spalding A.C., Anderson S.M., and Johnson G.L. Increased expression of death receptors 4 and 5 synergizes the apoptosis response to combined treatment with etoposide and TRAIL. Mol. Cell Biol. 20 (2000) 205-212
-
(2000)
Mol. Cell Biol.
, vol.20
, pp. 205-212
-
-
Gibson, S.B.1
Oyer, R.2
Spalding, A.C.3
Anderson, S.M.4
Johnson, G.L.5
-
47
-
-
0035863523
-
Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels
-
Nimmanapalli R., Perkins C.L., Orlando M., O'Bryan E., Nguyen D., and Bhalla K.N. Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels. Cancer Res. 61 (2001) 759-763
-
(2001)
Cancer Res.
, vol.61
, pp. 759-763
-
-
Nimmanapalli, R.1
Perkins, C.L.2
Orlando, M.3
O'Bryan, E.4
Nguyen, D.5
Bhalla, K.N.6
-
48
-
-
0033839749
-
Chemotherapeutic agents augment TRAIL-induced apoptosis in human hepatocellular carcinoma cell lines
-
Yamanaka T., Shiraki K., Sugimoto K., Ito T., Fujikawa K., Ito M., Takase K., Moriyama M., Nakano T., and Suzuki A. Chemotherapeutic agents augment TRAIL-induced apoptosis in human hepatocellular carcinoma cell lines. Hepatology 32 (2000) 482-490
-
(2000)
Hepatology
, vol.32
, pp. 482-490
-
-
Yamanaka, T.1
Shiraki, K.2
Sugimoto, K.3
Ito, T.4
Fujikawa, K.5
Ito, M.6
Takase, K.7
Moriyama, M.8
Nakano, T.9
Suzuki, A.10
-
49
-
-
33745228422
-
Cardiac glycosides initiate Apo2L/TRAIL-induced apoptosis in non-small cell lung cancer cells by up-regulation of death receptors 4 and 5
-
Frese S., Frese-Schaper M., Andres A.C., Miescher D., Zumkehr B., and Schmid R.A. Cardiac glycosides initiate Apo2L/TRAIL-induced apoptosis in non-small cell lung cancer cells by up-regulation of death receptors 4 and 5. Cancer Res. 66 (2006) 5867-5874
-
(2006)
Cancer Res.
, vol.66
, pp. 5867-5874
-
-
Frese, S.1
Frese-Schaper, M.2
Andres, A.C.3
Miescher, D.4
Zumkehr, B.5
Schmid, R.A.6
|